Trial Information
Bioactive Glass (S53P4) as Bone Graft Substitute in Operative Treatment of Depressed Lateral Condyle Fractures, Benign Bone Tumour Cavities and in Spinal Fusion - a 10 Years Follow-up and Bone Density Study.
Inclusion Criteria:
- Written informed consent obtained; Participation of previous clinical investigation
with bioactive glass
Exclusion Criteria:
- The subject is unlikely to adhere to study procedures
- Concurrent disease or condition that in the opinion of the investigator is
contraindicating participation
- Simultaneous participation in another medical device or investigational drug trial
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Cross-Sectional
Principal Investigator
Nina Lindfors, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Turku University Hospital/Helsinki University Hospital
Authority:
Finland: Finnish Medicines Agency
Study ID:
1005-3
NCT ID:
NCT00935870
Start Date:
January 2008
Completion Date:
February 2009
Related Keywords:
- Depressed Lateral Condyle Fracture
- Benign Bone Tumour Cavity
- Spinal Fusion
- Bone Neoplasms
- Fractures, Bone
- Depression